ACTOS DRUG INJURY SETTLEMENT
Bloomberg News reports that Takeda Pharamaceuticals Company, manufacturer of the Type 2 diabetes oral medicine ACTOS®, has recently agreed to pay $2.2 billion dollars to resolve claims of hiding the serious side effects of heart failure and the increased risk of bladder cancer from its customers. (Bloomberg News: Takeda Offers $2.2 Billion to Settlement Actos Drug Cases)
SHELLER ATTORNEYS ARE REPRESENTING CLIENTS INJURED BY ACTOS
Actos® drugs include the following products:
- Actoplus Met®
- ActoPlus Met XR®
The generic names for the drug and in combination with others are Pioglitazone and Pioglitazone Hydrochloride and metformin hydrochloride.
If you have a diagnosis of bladder cancer and have been taking ACTOS® for more than one year, contact us now by filling out the form on this page or calling 800-883-2299 for a no obligation consultation about your legal rights.